NPAS2 dampens chemo-sensitivity of lung adenocarcinoma cells by enhancing DNA damage repair

Abstract Chemotherapeutic agents, including cisplatin, have remained a cornerstone of lung adenocarcinoma (LUAD) treatment and continue to play an essential role in clinical practice, despite remarkable progress in therapeutic strategies. Hence, a thorough comprehension of the molecular mechanisms u...

Full description

Bibliographic Details
Main Authors: Youyu Zhang, Yuqiao Chen, Wentao Huang, Yuan Zhou, Ya Wang, Kai Fu, Wei Zhuang
Format: Article
Language:English
Published: Nature Publishing Group 2024-01-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-023-06256-3
_version_ 1797273056064831488
author Youyu Zhang
Yuqiao Chen
Wentao Huang
Yuan Zhou
Ya Wang
Kai Fu
Wei Zhuang
author_facet Youyu Zhang
Yuqiao Chen
Wentao Huang
Yuan Zhou
Ya Wang
Kai Fu
Wei Zhuang
author_sort Youyu Zhang
collection DOAJ
description Abstract Chemotherapeutic agents, including cisplatin, have remained a cornerstone of lung adenocarcinoma (LUAD) treatment and continue to play an essential role in clinical practice, despite remarkable progress in therapeutic strategies. Hence, a thorough comprehension of the molecular mechanisms underlying chemotherapeutic agent resistance is paramount. Our investigation centered on the potential involvement of the NPAS2 gene in LUAD, which is highly expressed in tumors and its high expression has been associated with unfavorable overall survival rates in patients. Intriguingly, we observed that the depletion of NPAS2 in LUAD cells resulted in increased susceptibility to cisplatin treatment. Furthermore, mRNA sequencing analysis revealed that NPAS2 deficiency downregulated genes crucial to DNA repair. Additionally, NPAS2 depletion significantly impairs γH2AX accumulation, a pivotal component of the DNA damage response. Further investigation demonstrates that NPAS2 plays a crucial role in DNA double-strand breakage repair via homology-directed repair (HDR). Our inquiry into the molecular mechanisms underlying NPAS2 regulation of DDR revealed that it may enhance the stability of H2AX mRNA by binding to its mRNA, thereby upregulating the DNA damage repair pathway. In-vivo experiments further confirmed the crucial role of NPAS2 in modulating the effect of cisplatin in LUAD. Taken together, our findings suggest that NPAS2 binds to and enhances the stability of H2AX mRNA, thereby decreasing the sensitivity of tumor cells to chemotherapy by augmenting DNA damage repair.
first_indexed 2024-03-07T14:39:05Z
format Article
id doaj.art-b5aa84942f024487b095a0fa1452e8e1
institution Directory Open Access Journal
issn 2041-4889
language English
last_indexed 2024-03-07T14:39:05Z
publishDate 2024-01-01
publisher Nature Publishing Group
record_format Article
series Cell Death and Disease
spelling doaj.art-b5aa84942f024487b095a0fa1452e8e12024-03-05T20:30:38ZengNature Publishing GroupCell Death and Disease2041-48892024-01-0115111210.1038/s41419-023-06256-3NPAS2 dampens chemo-sensitivity of lung adenocarcinoma cells by enhancing DNA damage repairYouyu Zhang0Yuqiao Chen1Wentao Huang2Yuan Zhou3Ya Wang4Kai Fu5Wei Zhuang6Institute of Molecular Precision Medicine and Hunan Key Laboratory of Molecular Precision Medicine, Department of General Surgery, Xiangya Hospital, Central South UniversityInstitute of Molecular Precision Medicine and Hunan Key Laboratory of Molecular Precision Medicine, Department of General Surgery, Xiangya Hospital, Central South UniversityDepartment of Thoracic Surgery, Xiangya Hospital, Central South UniversityDepartment of Thoracic Surgery, Xiangya Hospital, Central South UniversityInstitute of Molecular Precision Medicine and Hunan Key Laboratory of Molecular Precision Medicine, Department of General Surgery, Xiangya Hospital, Central South UniversityInstitute of Molecular Precision Medicine and Hunan Key Laboratory of Molecular Precision Medicine, Department of General Surgery, Xiangya Hospital, Central South UniversityDepartment of Thoracic Surgery, Xiangya Hospital, Central South UniversityAbstract Chemotherapeutic agents, including cisplatin, have remained a cornerstone of lung adenocarcinoma (LUAD) treatment and continue to play an essential role in clinical practice, despite remarkable progress in therapeutic strategies. Hence, a thorough comprehension of the molecular mechanisms underlying chemotherapeutic agent resistance is paramount. Our investigation centered on the potential involvement of the NPAS2 gene in LUAD, which is highly expressed in tumors and its high expression has been associated with unfavorable overall survival rates in patients. Intriguingly, we observed that the depletion of NPAS2 in LUAD cells resulted in increased susceptibility to cisplatin treatment. Furthermore, mRNA sequencing analysis revealed that NPAS2 deficiency downregulated genes crucial to DNA repair. Additionally, NPAS2 depletion significantly impairs γH2AX accumulation, a pivotal component of the DNA damage response. Further investigation demonstrates that NPAS2 plays a crucial role in DNA double-strand breakage repair via homology-directed repair (HDR). Our inquiry into the molecular mechanisms underlying NPAS2 regulation of DDR revealed that it may enhance the stability of H2AX mRNA by binding to its mRNA, thereby upregulating the DNA damage repair pathway. In-vivo experiments further confirmed the crucial role of NPAS2 in modulating the effect of cisplatin in LUAD. Taken together, our findings suggest that NPAS2 binds to and enhances the stability of H2AX mRNA, thereby decreasing the sensitivity of tumor cells to chemotherapy by augmenting DNA damage repair.https://doi.org/10.1038/s41419-023-06256-3
spellingShingle Youyu Zhang
Yuqiao Chen
Wentao Huang
Yuan Zhou
Ya Wang
Kai Fu
Wei Zhuang
NPAS2 dampens chemo-sensitivity of lung adenocarcinoma cells by enhancing DNA damage repair
Cell Death and Disease
title NPAS2 dampens chemo-sensitivity of lung adenocarcinoma cells by enhancing DNA damage repair
title_full NPAS2 dampens chemo-sensitivity of lung adenocarcinoma cells by enhancing DNA damage repair
title_fullStr NPAS2 dampens chemo-sensitivity of lung adenocarcinoma cells by enhancing DNA damage repair
title_full_unstemmed NPAS2 dampens chemo-sensitivity of lung adenocarcinoma cells by enhancing DNA damage repair
title_short NPAS2 dampens chemo-sensitivity of lung adenocarcinoma cells by enhancing DNA damage repair
title_sort npas2 dampens chemo sensitivity of lung adenocarcinoma cells by enhancing dna damage repair
url https://doi.org/10.1038/s41419-023-06256-3
work_keys_str_mv AT youyuzhang npas2dampenschemosensitivityoflungadenocarcinomacellsbyenhancingdnadamagerepair
AT yuqiaochen npas2dampenschemosensitivityoflungadenocarcinomacellsbyenhancingdnadamagerepair
AT wentaohuang npas2dampenschemosensitivityoflungadenocarcinomacellsbyenhancingdnadamagerepair
AT yuanzhou npas2dampenschemosensitivityoflungadenocarcinomacellsbyenhancingdnadamagerepair
AT yawang npas2dampenschemosensitivityoflungadenocarcinomacellsbyenhancingdnadamagerepair
AT kaifu npas2dampenschemosensitivityoflungadenocarcinomacellsbyenhancingdnadamagerepair
AT weizhuang npas2dampenschemosensitivityoflungadenocarcinomacellsbyenhancingdnadamagerepair